🇺🇸 FDA
Pipeline program

Vedolizumab Placebo

Vedolizumab-4004

Approved small_molecule completed

Quick answer

Vedolizumab Placebo for Pouchitis is a Approved program (small_molecule) at Takeda with 1 ClinicalTrials.gov record(s).

Program details

Company
Takeda
Indication
Pouchitis
Phase
Approved
Modality
small_molecule
Status
completed

Clinical trials